Cargando…
Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212201/ https://www.ncbi.nlm.nih.gov/pubmed/35729471 http://dx.doi.org/10.1007/s12020-022-03109-5 |
| _version_ | 1784730527820939264 |
|---|---|
| author | Dorcely, Brenda Sifonte, Eliud Popp, Collin Divakaran, Anjana Katz, Karin Musleh, Sarah Jagannathan, Ram Curran, Margaret Sevick, Mary Ann Aleman, José O. Goldberg, Ira J. Bergman, Michael |
| author_facet | Dorcely, Brenda Sifonte, Eliud Popp, Collin Divakaran, Anjana Katz, Karin Musleh, Sarah Jagannathan, Ram Curran, Margaret Sevick, Mary Ann Aleman, José O. Goldberg, Ira J. Bergman, Michael |
| author_sort | Dorcely, Brenda |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212201 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92122012022-06-22 Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study Dorcely, Brenda Sifonte, Eliud Popp, Collin Divakaran, Anjana Katz, Karin Musleh, Sarah Jagannathan, Ram Curran, Margaret Sevick, Mary Ann Aleman, José O. Goldberg, Ira J. Bergman, Michael Endocrine Brief Report Springer US 2022-06-21 2022 /pmc/articles/PMC9212201/ /pubmed/35729471 http://dx.doi.org/10.1007/s12020-022-03109-5 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Brief Report Dorcely, Brenda Sifonte, Eliud Popp, Collin Divakaran, Anjana Katz, Karin Musleh, Sarah Jagannathan, Ram Curran, Margaret Sevick, Mary Ann Aleman, José O. Goldberg, Ira J. Bergman, Michael Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study |
| title | Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study |
| title_full | Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study |
| title_fullStr | Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study |
| title_full_unstemmed | Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study |
| title_short | Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study |
| title_sort | continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with hba1c < 5.7%: a pilot study |
| topic | Brief Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212201/ https://www.ncbi.nlm.nih.gov/pubmed/35729471 http://dx.doi.org/10.1007/s12020-022-03109-5 |
| work_keys_str_mv | AT dorcelybrenda continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT sifonteeliud continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT poppcollin continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT divakarananjana continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT katzkarin continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT muslehsarah continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT jagannathanram continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT curranmargaret continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT sevickmaryann continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT alemanjoseo continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT goldbergiraj continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy AT bergmanmichael continuousglucosemonitoringand1hplasmaglucoseidentifiesglycemicvariabilityanddysglycemiainhighriskindividualswithhba1c57apilotstudy |